TY  - GEN
AU  - Johnson,Brett E
AU  - Mazor,Tali
AU  - Hong,Chibo
AU  - Barnes,Michael
AU  - Aihara,Koki
AU  - McLean,Cory Y
AU  - Fouse,Shaun D
AU  - Yamamoto,Shogo
AU  - Ueda,Hiroki
AU  - Tatsuno,Kenji
AU  - Asthana,Saurabh
AU  - Jalbert,Llewellyn E
AU  - Nelson,Sarah J
AU  - Bollen,Andrew W
AU  - Gustafson,W Clay
AU  - Charron,Elise
AU  - Weiss,William A
AU  - Smirnov,Ivan V
AU  - Song,Jun S
AU  - Olshen,Adam B
AU  - Cha,Soonmee
AU  - Zhao,Yongjun
AU  - Moore,Richard A
AU  - Mungall,Andrew J
AU  - Jones,Steven J M
AU  - Hirst,Martin
AU  - Marra,Marco A
AU  - Saito,Nobuhito
AU  - Aburatani,Hiroyuki
AU  - Mukasa,Akitake
AU  - Berger,Mitchel S
AU  - Chang,Susan M
AU  - Taylor,Barry S
AU  - Costello,Joseph F
TI  - Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
SN  - 1095-9203
PY  - 2014///0123
KW  - Antineoplastic Agents, Alkylating
KW  - adverse effects
KW  - Brain
KW  - drug effects
KW  - Brain Neoplasms
KW  - drug therapy
KW  - DNA Helicases
KW  - genetics
KW  - DNA Mutational Analysis
KW  - Dacarbazine
KW  - Glioma
KW  - Humans
KW  - Mutagenesis
KW  - Neoplasm Grading
KW  - Neoplasm Recurrence, Local
KW  - chemically induced
KW  - Nuclear Proteins
KW  - Proto-Oncogene Proteins B-raf
KW  - Proto-Oncogene Proteins c-akt
KW  - TOR Serine-Threonine Kinases
KW  - Temozolomide
KW  - Transcription Factors
KW  - Tumor Suppressor Protein p53
KW  - X-linked Nuclear Protein
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1126/science.1239947
ER  -